Firefly luciferase as a marker for herpesvirus (pseudorabies virus) replication in vitro and in vivo
Ferenc Kovfics Sz. t and Thomas C. Mettenleiter* Animals, P.O. Box 11 49, Germany Insertion of reporter genes into complex viral genomes and monitoring virus replication by detecting the corresponding protein products is increasingly used in pathogenesis studies. We present here the isolation and characterization of a recombinant neurotropic alphaherpesvirus, pseudorabies virus (PrV), which stably carries the gene encoding firefly luciferase. To express the enzyme the complete open reading frame for luciferase was fused to the promoter and first seven codons of the non-essential glycoprotein gX gene of PrV. A recombinant PrV carrying the luciferase gene inserted into the gX gene and exhibiting strong luciferase activity after infection of cultured cells was further characterized. Kinetic analyses showed that luciferase activity was detectable as early as 90 min after infection. Luciferase expression could be monitored in cell extracts in a luminometer. For facilitating plaque isolation of luciferase recombinant viruses it was also visualized in situ on sensitive film. Kinetic experiments in mice proved the suitability of luciferase as an excellent marker for following herpesvirus spread in the animal. By way of luciferase detection we show that PrV invasion of the central nervous system after intranasal infection of mice occurred independently of
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Introduction
Pseudorabies virus (PrV), a member of the alphaherpesvirus subgroup of the Herpesviridae, is the causative agent of Aujeszky's disease (AD) which mainly affects pigs (reviewed in Gustafson, 1975) . AD in pigs is characterized by extensive neural symptoms caused by viral invasion of the central nervous system (CNS) probably after replication in peripheral mucosal tissues (Pol et al., 1989 (Pol et al., , 1991 . In addition, primary replication is usually detected in the lung (Baskerville, 1973) where macrophages become infected (Iglesias et al., 1989) ; their subsequent depletion might play a role in the emergence of opportunistic bacterial infections. As is characteristic for alphaherpesviruses PrV can establish latent, reactivatable infections in neural cells (Rziha et al., 1986) .
Although extensive studies have been performed on herpesvirus pathogenesis in model systems such as herpes simplex virus (HSV) infection in mice, only limited information is available from natural virus-host systems. In particular, pathogenesis of PrV in pigs is still poorly understood. To follow virus infection in cell culture and in the animal in a sensitive and convenient way, reporter genes have been introduced into nonessential regions of the genomes of several complex viruses. Most widely used is the lacZ gene from Escherich& coli which encodes the enzyme fl-galactosidase. Expression of fl-galactosidase from recombinant viral genomes can be analysed after addition of chromogenic substrates. This marker appears useful for selecting viral mutants (Mettenleiter et al., 1990) or identifying target cells in histological sections (Ho & Mocarski, 1988) . However, sensitivity is limited and in infected organisms background problems often appear due to high endogenous fl-galactosidase activity (unpublished results). To overcome these difficulties other reporter proteins are desirable.
The luciferase gene isolated from Photinus pyralis is increasingly used as a reporter gene in molecular biology (Gould & Subramani, 1988; Subramani & DeLuca, 1989) . It encodes a protein of 62K which catalyses a lightemitting reaction when incubated with ATP and luciferin (DeWet et al., 1987) . This light emission can be 0001-0440 © 1991 SGM detected very sensitively in a luminometer (Nguyen et al., 1988) or can even be recorded on film . Since detection of luciferase activity is more sensitive than detection of other marker proteins (Alam and Cook, 1990) and since background problems virtually do not exist luciferase has become an attractive marker for promoter analyses and gene expression studies (Ow et al., 1986; Williams et al., 1989) . Recently, a luciferase cDNA copy was introduced into the genome of vaccinia, a virus that is already widely used as a vector (Rodriguez et al., t988) . PrV is also used as a viral vector for expression of foreign genes (Keeler et al., 1986; Thomsen et al., 1987b; van Zijl et al., 1991) and appears more promising as a recombinant vaccine for use in animals than vaccinia virus because it is not pathogenic for humans (Wittmann & Rziha, 1989) . However, little is known about tissue tropism of the virus in the infected animal and particularly about possible alterations in recombinant PrV strains expressing foreign genes. To analyse these questions we started by constructing a PrV glycoprotein gX-luciferase fusion gene and inserting this into the PrV genome. Our results establish firefly luciferase as an excellent marker for analysing herpesvirus pathogenesis in the infected animal.
Methods
Viruses and cells. PrV strain Ka (Kaplan & Vatter, 1959) was propagated in either bovine kidney (MDBK) or pig kidney (PSEK) cells. Transfections were performed into African green monkey kidney (Vero) cells. The gI-mutant was obtained after deletion of a BstEIISphI fragment from the body of the gI gene (Mettenleiter et al., 1987a) .
Transfections. Purified DNA from the PrV gX-fl-galactosidaseexpressing mutant 1112 (Mettenleiter et al., 1990) was used for cotransfection with plasmid DNA using the calcium phosphate coprecipitation technique (Graham & van der Eb, 1973) . After complete c.p.e, was observed, viral progeny was harvested and plaqueassayed under an agarose overlay containing 300 ~tg/ml of Bluo-gal (Gibco-BRL). Plaques produced by recombinant viruses carrying the luciferase gene were expected to stain white, and plaques produced by the parental fl-galactosidase-expressing virus, blue. White plaques were picked, grown in 24-well tissue culture plates and analysed by dot spot hybridization (Mettenleiter et al., 1987a ) using a luciferase-specific probe. Supernatants giving positive hybridization signals were analysed further for luciferase activity.
Analysis of DNA from recombinant PrV. PrV DNA was isolated from purified virions as described (Ben-Porat et al., 1974) . DNA was cleaved with BamHI and fragments were separated in a 0.8% agarose gel. Southern blotting and hybridization with specific 32p-labelled probes was performed using standard procedures (Sambrook et al., 1989) .
Luciferase assay. Infected culture cells from either 5 cm or 10 cm dishes were scraped into 1 ml of luciferase extraction buffer (100 mMTris-phosphate pH 8.0, 1 mM-DTT), pelleted in a centrifuge and the pellet was resuspended in 100 ~tl extraction buffer. For cell lysis the suspension was frozen three times in liquid nitrogen and thawed at 37 °C. Cellular debris was pelleted and the supernatant used for determination of luciferase activity in a luminometer (Berthold LB9501). The luciferase substrate solution contained 100 mM-sodium arsenate, 7.5 mM-ATP, 15 mu-MgSO4 and 1.0 mu-luciferin (Boehringer-Mannheim). Data were recorded as relative light units (RLU). In our assay system 1 pg of luciferase yielded approximately 1 x 103 RLU. Organs of infected animals were minced in luciferase extraction buffer supplemented by 1 mM-PMSF (Rodriguez et al., 1988) . After three cycles of freezing and thawing the organ debris was pelleted and the supernatant used for determination of luciferase activity.
Animal experiments. Ether-anaesthetized six-week-old female BALB/c mice were infected intranasally with 106 p.f.u, of the respective virus strain. For establishing a lung infection the inoculum consisted of a volume of 50 ~tl. Lung infection could be prevented by inoculating only 5 ~tl of virus suspension. At the indicated times after infection two mice per time point were sacrificed, and their organs were removed and minced in luciferase extraction buffer. One aliquot was used for the titration of infectious virus and another for the determination of luciferase activity.
Results
Construction of gX-luciferase fusion gene
Plasmid pBLuc containing a luciferase gene which had been altered by introduction of a N-terminal extension of eight codons and additional N-terminal unique restriction sites (Reil & Hauser, 1990) was cleaved with NcoI and SmaI. After a partial fill-in of the 5' NcoI overhang without dGTP using Klenow polymerase, a one base overhang consisting of a cytosine residue remained. This was ligated to a one base guanine overhang that remained after cleaving the SphI fragment containing the gX gene with BamHI and filling in the end with all nucleotides except dCTP (Fig. 1) . After an overnight ligation at 14 °C the remaining ends were completely filled in with Klenow polymerase and ligated. Recombinant plasmids were picked and sequenced to verify correct fusion of the first seven codons of the gX gene to the luciferase gene. The resulting expression construct contains the first seven codons of the gX gene and approximately 800 bp of upstream sequences fused to the initiation methionine of the luciferase gene ( Fig. 1 ). This plasmid was called TT-200. The construct was tested for transient expression after transfection and superinfection with PrV. Cell extracts were analysed for luciferase activity and yielded positive results (not shown).
Isolation of luciferase-expressing PrV
To isolate a luciferase-expressing virus mutant DNA from PrV recombinant 1112 containing the fl-galactosidase gene under control of the gX promoter (Mettenleiter & Rauh, 1990) was used for cotransfection with plasmid TT-200. Viral progeny was screened for the appearance of white plaques under a Bluo-gal overlay. Plaques produced by the parental recombinant expressing flgalactosidase stained blue under these conditions (Mettenleiter & Rauh, 1990) . Homologous recombination between TT-200 and the corresponding sequences in the genomic viral gX gene should result in loss of the flgalactosidase gene leading to a white plaque phenotype and acquisition of the luciferase gene. White plaques were picked and analysed in dot spot hybridization using a luciferase-specific probe for the presence of luciferase sequences. Positive virus suspensions were analysed for luciferase activity and plaque-purified three times. One isolate, A916, was selected for further experiments. The luciferase recombinant gI-mutant A916/C1 was constructed similarly starting with a gI deletion mutant of PrV strain Ka (Mettenleiter et al., 1987a) . Correct insertion of the luciferase gene into the PRV genome was analysed by Southern blot hybridization of viral DNA from wild-type (wt) PrV (Fig. 2 , lanes 1), the gX-flgalactosidase recombinant 1112 (Fig. 2 , lanes 2) and luciferase recombinant A916 (Fig. 2 , lanes 3). As can be seen in Fig. 2 (a), compared to wt DNA mutant 1112 exhibits one additional fragment migrating between BamHI fragments 6 and 7 consisting of the fusion of fl-galactosidase sequences to fragment BamHI 10 which consequently does not appear (Mettenleiter et al., 1990) . The luciferase recombinant A916 shows an additional fragment of approximately 9 kb migrating between BamHI fragments 4 and 5 (marked by arrow in Fig. 2a Fig. 2 . Genome analysis of luciferase recombinant PrV. DNA isolated from wt PrV (Ka) (lanes 1), from the fl-galactosidaseexpressing mutant 1112 (lanes 2) and from the luciferase recombinant A916 (lanes 3) was cleaved with BamHI and fragments separated in a 0.8~ agarose gel. In (a) the ethidium bromide-stained gel is shown. The arrow points to the mutant fragment in A916 DNA. To prove correct insertion of the luciferase gene and concomitant deletion of the fl-galactosidase gene, hybridizations were performed using a luciferase-specific probe (b), a//-galactosidase-specific probe (c), fragment BamHI 7 (d) and fragment BamHI 10 (e). For location of fragments see Fig. 1 .
expected fusion of the luciferase gene at the 5' end to BamHI 10 where a BamHI site in the luciferase gene remains ( Fig. 1 ) and at the 3' end to BamHI 7 with concomitant loss of the BamHI site. Hybridization signals of wt PrV DNA and DNA of fl-galactosidaseexpressing mutant 1112 (lanes 2) were as expected. Fragment BamHI 10 recognizes two wt BamHI fragments, 10 and 12, since they are derived in part from the inverted repeat regions of the viral genome and contain identical sequences (see Fig. 1 ). The gI-luc ÷ recombinant A916/C1 showed similar hybridization patterns in the genomic region of interest (data not shown).
Kinetics of luciferase expression in recombinant PrV
Herpesviral genes are strictly regulated in a cascade fashion (Wagner, 1985) . The promoter for the glycoprotein gX gene, used for the construction of the fusion gene, had previously been proposed to be regulated as an 'early' or/%class promoter (Ben-Porat & Kaplan, 1985; Reaet al., 1985) . To analyse luciferase expression during recombinant A916 replication cells were infected at a multiplicity of 5 and cell lysates prepared at different times after infection. Luciferase activity was measured in a luminometer and recorded in RLU (Fig. 3) . It is evident that luciferase activity could be detected as early as 90 min post-infection (p.i. A916 or wt PrV. A t either 5 h or 18 h p.i. cells were harvested and cell lysates analysed for luciferase activity. F i v e hours after infection of cells with 1000 p.f.u, of m u t a n t A916 luciferase activity could be shown (Fig. 4) . After 18 h even 10 p.f.u, used for infection were clearly demonstrable. It is evident that luciferase activity increased linearly with increasing p.f.u, in the inoculum until reaching a plateau at a p p r o x i m a t e l y 106 R L U . Similar results were o b t a i n e d irrespective of the n u m b e r of cells used for infection, i.e. they were therefore not d e p e n d e n t on the m.o.i, but solely on the a m o u n t of virus used for infection as long as the m.o.i, was lower than 1, i.e. did not exceed one infectious virion per cell. M e a s u r e m e n t of luciferase activity at k n o w n times p.i. can therefore also serve to d e t e r m i n e the a m o u n t of infectious virus in the inoculum. F u r t h e r m o r e we tested whether expression of the g Xluciferase fusion gene could be visualized on film. To this end serial dilutions o f r e c o m b i n a n t A916 were plated onto 5 cm tissue culture dishes. After 1 h adsorption at 37 °C the inoculum was r e m o v e d and the cells overlaid with 1 ~ methylcellulose in M E M . Two days p . i . the overlay was r e m o v e d and the cells were washed twice with PBS. One set of parallel samples was fixed in 3 f o r m a l d e h y d e and stained with crystal violet (Fig. 5 a, c) . The other set was placed onto K o d a k Tmax400 film and overlaid in the d a r k with 1 ml luciferase substrate solution containing 1 5~ D M S O (Fig. 5b, d) . A f t e r a 3 h exposure the films were developed. The light-emitting plaques yielded clearly identifiable signals. Thererafter, a similar assay using a luciferase substrate solution overlay containing 1 ~ agarose was used to identify and isolate luciferase-expressing virus r e c o m b i n a n t s from transfection progeny (data not shown).
Detection of luciferase activity in infected animals
To analyse whether luciferase expression can be used to m o n i t o r herpesvirus replication 'n vivo two mice were * Two mice were infected intranasally with 106 p.f.u, of mutant A916 each. At 84 h p.i. when exhibiting severe symptoms they were sacrificed and organ extracts prepared. One aliquot was used for determination of luciferase activity, and one aliquot used for virus isolation as described in Methods.
In organ extracts from wt PrV-infected animals background values of between 7 x 10 ° and 1.8 x 10 ~ RLU were observed.
:~ TG, trigeminal ganglion; O1. bulb, olfactory bulb. infected intranasally with 106 p.f.u, of mutant A916 each. At 84 h p.i. when exhibiting severe symptoms of PrV infection they were sacrificed, organ lysates prepared and analysed. Luciferase activity was detected in organs known to be targets for PrV infection, i.e. the lung and the central nervous system (Table 1 ). In all cases tested there was a good correlation between luciferase activity and virus recovery (Table 1) . Extracts from different organs differ in their optical density (OD) which might interfere with the sensitivity of detection of the emitted light. To test this assumption organ extracts from non-infected mice were mixed with standardized amounts of lysates from A916-infected culture cells. The yield of RLU from the cell culture lysate was considered as 100~. As can be seen in Fig. 6 there is no significant difference in RLU yield from cell lysate and lysates obtained from neural tissues. However, only 30 to 80~o of input luciferase activity could be recorded in extracts from respiratory organs (lung, trachea and nose), 50 to 65 ~o in lymphatic organs (tonsil, thymus) and less than 40~ in heart, spleen and kidney. Only 10~o of input luciferase activity was detectable in liver extracts.
One of our goals is analysing in more detail the pathogenesis of PrV in the infected host using reporter protein detection. In previous experiments we noted after intranasal infection of mice a significant difference regarding virus replication in the lung which is a primary target of PrV. On several occasions animals were found negative for virus replication in the lung although they showed CNS symptoms similar to those of the lunginfected animals. To analyse in more detail whether virus replication in the lung plays a role in the progress of disease 24 mice were infected intranasally with 106 p.f.u. of luciferase recombinant PrV mutant A916. To establish lung infections the inoculum was contained in a 50 ~tl volume (group I: lung +) whereas lung infection could be avoided reproducibly when a smaller volume (5 ~tl) was used for infection (group II: lung-). Both groups showed the same progress of disease, symptoms appeared at similar times p.i. and animals from both groups were dead or dying at day 4 p.i. This indicated that infection of the lung is not relevant to a fatal outcome of the disease.
At 24, 48, 60, 72, 84 and 96 h p.i. two mice per group were sacrificed and organs analysed for luciferase activity. (Only three animals, one lung-infected and two without lung infection, survived until 96 h p.i. in a moribund state.) As demonstrated in Fig. 7 group I showed high luciferase activity in lung homogenates indicating heavy infection. In contrast, group II remained luciferase-negative until the last time point, when some activity became detectable in the lung. Similar results were found for the thymus. Correlating with the onset and progress of symptoms, detection of luciferase activity in the CNS was remarkably similar between the two groups. In the trigeminal ganglion (TG) there was a slight delay in luciferase detection in group II, whereas in the medulla oblongata, in the brain stem and in the cerebellum no significant difference between the two groups could be found. Progress of the disease in the CNS is evident since luciferase activity was first detectable in the TG followed by the medulla oblongata and finally reaching other parts of the brain stem and the cerebellum. In the spinal cord luciferase activity first appeared in the cervical part followed by the thoracic part. In two mice the T G and medulla oblongata were luciferase-positive whereas no activity could be detected in the nasal mucosa. All the other animals exhibited luciferase activity in nasal mucosal tissues (data not shown). These results show that spread of the virus in the C N S and concomitant development of symptoms leading finally to death occurs independently of infection of the lung.
Pathogenesis of luciferase recombinant gI-PrV
Glycoprotein gI has recently been shown to play a role in PrV virulence in pigs and chicken (Mettenleiter et al., 1987b) . To obtain a direct comparison between isogenic gI + and gI-strains the gX-luciferase fusion gene was inserted into the gX gene of both viruses. Analysis of the resulting recombinants in cell culture showed no difference in growth or luciferase expression (not shown). Luciferase recombinants that were either gI + (group I, 10 animals) or g I -(group II, 10 animals) were then used for intranasal infection of mice. For standardization in this experiment lung infection was established in all animals. Symptoms in the gI+-infected group started at 24 h p.i. increasing in severity until moribund animals were sacrificed at 84 h p.i. In comparison, the gI--infected animals remained clinically healthy until 72 h p.i. when symptoms appeared which rapidly increased in intensity until moribund animals were sacrificed at the same time, 84 h p.i., as the gI+-infected mice. Detection ofluciferase activity parallels the clinical signs exactly (Fig. 8) . Whereas in group I there was a continuous increase in luciferase activity in the TG, medulla oblongata and brain stem starting at 24 to 48 h p.i., g I -PrV-infected mice showed a delay in the detection of luciferase activity, particularly in the medulla and brain stem where luciferase activity first became detectable at 72 h p.i. However, final activities were similar for both groups in the C N S (TG, medulla, brain stem and cerebellum) indicating vigorous g I -PrV replication in these organs.
With one exception, in all organs tested luciferase activities were lower in gI--infected mice than in gI +-infected animals. Two organs tested, thymus and olfactory bulb, did not show any sign of infection by the g I -PrV whereas luciferase activity from gI + PrV was clearly detectable. This indicates differences in organotropism between gI + and g I -PrV. Surprisingly, in the liver we found the opposite situation (Fig. 8) . Whereas luciferase-activity from gI-genomes was readily detectable as early as 48 h p.i. remaining at this level until the end of the experiment, no luciferase activity from gI + PrV could be found. This shows that deletion of gI not only negatively influences the organotropism of the mutant but also results in the infection of organs where wt virus could not be found.
From each animal virus reisolates were analysed by DNA restriction typing for stability of the luciferase insertion. During the course of the experiments the restriction pattern remained unaltered (data not shown).
Discussion
AD is an often fatal infection caused by the neurotropic alphaherpesvirus, PrV. Although losses occur mostly in the pig industry PrV has a very broad host range and is able to cause fatal infections in most other mammals except equidae and higher primates including humans. Owing to its economic importance, interest in AD has been high and studies on pathogenesis in model systems (chicken and mice) as well as the natural host, swine, have been performed (reviewed in Wittmann & Rziha, 1989) . However, only limited information is available relating to the course of the disease, organotropism of strains exhibiting different levels of virulence, influence of single viral genes and particularly specific target cells.
To facilitate detection of the virus in vivo we inserted the E. coli lacZ gene into several non-essential PrV genomic regions and showed that expression of //-galactosidase from recombinant PrV could be visualized by a chromogenic assay (Mettenleiter & Rauh, 1990) in histological thin sections (Loewy et al., 1991) . However, in organ extracts background problems due to endogenous //-galactosidase activity were often observed, limiting the use of this approach (unpublished observations). To overcome these problems and to obtain a marker that could be detected sensitively and easily in organ extracts of infected animals we chose another reporter gene encoding firefly luciferase (DeWet et al., 1987) as a marker for PrV replication in vitro and in vivo. To this end the complete luciferase coding sequence was fused to the promoter and the first seven codons of the gene encoding the non-essential PrV glycoprotein gX. A similar approach has recently proved successful for high level expression of //-galactosidase (Mettenleiter & Rauh, 1990) . The gX promoter is considered one of the strongest in the PrV genome and has been suggested to belong to the 'early' or//-class of herpesviral promoters (Ben-Porat & Kaplan, 1985; Rea et al., 1985) . In cell culture luciferase activity became detectable as early as 90 min after infection which is in agreement with /3-regulation of the fusion gene. Placing the luciferase gene behind promoters belonging to different kinetic classes could then be used to analyse gene expression from herpesviral genomes at different stages after infection.
Insertion of the luciferase reporter gene into the gX gene eliminates gX expression and might influence the in vivo behaviour of the virus. Comparison between wt PrV strains and isogenic gX-derivatives showed, however, that inactivation of the gX gene did not significantly affect virulence of the virus in either mice or pigs (Thomsen et al., 1987a) .
To initiate studies analysing kinetics of PrV infection in vivo, BALB/c mice were infected intranasally either to obtain heavy infection of the lung or to avoid lung infection. In both cases, animals showed similar progress of disease and identical times of death. This is reflected by the luciferase activities found in CNS tissues which were nearly identical in both groups. Despite loss of efficiency of photon detection during luciferase measurements in organ extracts with a high OD, e.g. liver, kidney and lung, in CNS tissues efficiencies that approximated 100% as compared to cell culture controls were obtained. In addition, our results indicate that at least in these inbred mice variation between individual animals was limited. Whether the same is true in outbred pig populations remains to be demonstrated. Our studies also show that productive infection of the lung appears not to be important for the outcome of PrV infection in mice. Since lung infection has been proposed to play an important role for PrV infection in pigs (Baskerville, 1973) we are currently investigating whether similar results can be obtained in pigs.
The non-essential glycoprotein gI has been shown to play a role in the expression of PrV virulence in both model systems (chicken) and the natural host (pig) (Mettenleiter et al., 1987b) . However, the reason for this diminished virulence in gI-strains is not clear. Our results show that when isogenic luciferase-recombinant gI ÷ and gI-strains were used for intranasal infection of mice, animals from both groups were dead or dying at the same time. However, whereas there was an early onset of symptoms which steadily increased in gI+-infected mice symptoms were delayed in the gI--infected group but once started developed more rapidly. This is also reflected in the luciferase activities which show a steady increase in gI+-infected animals. In contrast, a lag phase was observed in the CNS of gI--infected animals after which a steep increase in luciferase activity during the last 12 to 24 h before death could be observed. Luciferase activities finally reached similar values in both groups. This might be explained by a slower gI-replication in the periphery delaying entrance of the virus into the CNS.
However, once it entered neural tissues replication appeared to proceed at a significantly faster rate. Whether gI-PrV is indeed restricted in replication in peripheral tissues of mice is currently under investigation.
Deletion of gI influences organotropism of the virus as is evident from organs such as the thymus or olfactory bulb where luciferase activity could be demonstrated only after gI ÷ infection and not in gI-infected animals. Interestingly, the opposite is true for the liver. Here, so far in no case (at present more than 40 animals; unpublished results) could luciferase activity be detected after gI ÷ infection whereas gI-luciferase recombinant PrV appears to be able to enter the liver as early as 48 h p.i. It should be noted that the photon yield in liver homogenates amounted to less than 10% compared to cell culture lysates or lysates from neural tissues so that the actual amount of luciferase activity in liver might be up to 10-fold higher than could be detected. At present we cannot rule out that the wt virus does replicate to a certain extent in the liver although virus reisolation experiments proved to be negative (not shown). However, it is clear from our data that compared to the luciferase recombinant gI + PrV, gI-PrV appears to yield at least 10-fold higher luciferase activities in liver. It has been described that deletion of gI can confer upon the virus a selective growth advantage in certain cells such as chicken embryo fibroblasts (Mettenleiter et al., 1988) . This is attributable, at least in part, to a more efficient release of gI-PrV from these cells (Zsak et al., 1989) . Whether the same is true for mouse hepatocytes remains to be analysed.
Our results show that recombinant herpesvirus expressing functional firefly luciferase at levels that permit easy detection of virus replication in cell culture and in the infected animal can be isolated. Firefly luciferase therefore represents an excellent marker for herpesvirus replication in vitro and in vivo.
Pathogenesis of diseases caused by neurotropic herpesviruses has been studied mostly in model systems such as experimental infection of mice with herpes simplex virus. However, results from these artificial systems are difficult to interpret in terms of their importance for the natural host, i.e. humans. Our goal is the study of AD where findings derived from model systems such as the one presented here can be tested experimentally in the natural host. The sensitive and easy detection of luciferase activity in infected cells and organ extracts should greatly facilitate analyses of host, organ, and cell tropism of different herpesvirus strains and mutants and might also be helpful for studies on the mechanisms of herpesviral latency and reactivation.
